Glox Therapeutics secures £500K from a £3M fund to develop antibiotics targeting antimicrobial-resistant lung infections in ...

New cell therapy, Cilta-cel, shows promise in the treatment of multiple myeloma, providing a personalised approach with the ...

Rigel Pharmaceuticals has enrolled the first patient in a Phase I trial to evaluate fostamatinib as a treatment for sickle ...

Cancer Research UK, Cytovation, and the Norwegian Cancer Society collaborate to advance treatment for adrenocortical ...

Grifols has received a $21 million grant from The Michael J. Fox Foundation to fund a pioneering study aimed at identifying ...

Learn about the gut-brain connection in mental health and how targeting serotonin in the gut could revolutionise ...

New study reveals that TLE6 protein deficiency causes male infertility in mice. These findings suggest potential genetic ...

UVA researchers found that continuous glucose monitor data can predict nerve, eye, and kidney damage from type 1 diabetes.

Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.

Enhance compliance and quality in the health and wellness market with Eurofins' GMP certification programme for dietary and ...

Researchers at UVA have developed computer models to create targeted antibiotics, aiming to combat antibiotic resistance.

Download our latest report to discover how stem cell research is revolutionising treatments for chronic diseases, cancer and regenerative medicine. Dear readers, Welcome to our report on the latest ...